As companies look to become an Agentic Enterprise, success will depend on their workforce's ability to harness and apply ...

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting ...

Not every aspect of the 2026 regulations are set in stone yet, and the FIA has several ways to react after F1 testing in ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...

The true cost lies in presenteeism, employees who are physically present but cognitively depleted, emotionally dysregulated, ...

Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2 ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung ...

Scientists have long suspected that the trillions of microbes in our intestines do more than digest lunch, but new work goes ...

Open‑source Android apps are great to have if you want reliable and often free alternatives to software you'd otherwise have ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...